Complex Abdominal Wall Reconstruction Using Biologic Mesh
1 other identifier
observational
250
1 country
1
Brief Summary
The purpose of this study is to determine how the patient factors, co-morbid conditions, pre-operative workup, anatomy of the defect, reconstruction details, operative techniques, and type of repairs contribute to the final outcome of abdominal wall reconstruction. The outcomes of interest are: in-hospital complications, discharge disposition, hospital and ICU length of stay, long term follow-up (recurrence, reoperation, and explantation rates).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 7, 2017
CompletedFirst Submitted
Initial submission to the registry
August 13, 2020
CompletedFirst Posted
Study publicly available on registry
March 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2022
CompletedMarch 3, 2021
March 1, 2021
5 years
August 13, 2020
March 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
In Hospital Complications
Infection, re-procedures, explantation rates, length of hospital stay and ICU stay.
3 years
Eligibility Criteria
All patients aged 18 years and above undergoing Abdominal wall reconstruction with biological mesh irrespective of gender, ethnicity, socio-economic status will be included in the study.
You may qualify if:
- All patients aged 18 years and above undergoing Abdominal wall reconstruction with biological mesh.
You may not qualify if:
- Vulnerable patient population (Neonates, Prisoners, Pregnant) will not be included in our study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westchester Medical center
Valhalla, New York, 10595, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rifat Latifi, MD
Chairman Department of Surgery
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, General surgery
Study Record Dates
First Submitted
August 13, 2020
First Posted
March 3, 2021
Study Start
July 7, 2017
Primary Completion
July 6, 2022
Study Completion
December 6, 2022
Last Updated
March 3, 2021
Record last verified: 2021-03